login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Biasi calls time on carotid stenting


Friday, 20 Feb 2009 10:24



A standard time limit for carotid artery stenting procedures was suggested by Giorgio Biasi of the University of Milano-Bicocca, Italy, speaking at the International Congress on Endovascular Interventions XXII in Scottsdale, Arizona, USA, this month.


Biasi presented the final results of the RISC study (Registro Italiano per lo Stenting Carotideo), a study of 1,350 cases, which found that the minimally-invasive procedure has good long-term results, both in terms of neurological complications and restenosis.


The study aimed to collect data on carotid artery stenting in a "real world" setting.


The data was compiled by professionals from across disciplines concerned with preventing stroke due to carotid plaques. "The interesting point is," said Biasi, "that the major components - vascular surgeons, radiologists and cardiologists - were roughly equally represented."


Each of the study centres was free to use different techniques and devices.


Patient follow-up took place at one, six, 12 and 24 months with computed tomography or magnetic resonance imaging, always in the presence of an independent neurologist. The primary endpoints of the study were 30-day combined any stroke and death rate, restenosis at 24 months, and stroke and death rate at 24 months.


The study found a 30-day stroke and death rate of 2.4%. Biasi highlighted a peak in complication rates in patients aged between 70 and 80 years, which fell in those over 80 years of age.


A difference between experienced and inexperienced centres (those that had performed more or less than 30 procedures respectively) was observed, but this, he said, was not found to be significant (p=.09). He also showed that the data strongly supported statin administration and the use of embolic protection devices.


"The total procedure time was very important. When the time was over 60 minutes, there was a great difference from those taking less than 30 minutes," he said.


"The presence of calcified plaques is also very important [increasing the chance of stroke and death], and the least important factor is the percentage of stenosis."


The study found no statistically significant difference between open and closed cell stent designs.


Beyond 30 days, there were 23 deaths up to two years, 15 of which were from non-neurological causes. There were 13 strokes recorded in this period and a rate of new restenosis of 4.4%.




Add New Comment

Most popular


Biolas introduces VariClose in Europe
Thursday, 16 Jul 2015
After the European launch in April 2015, Biolas has introduced the VariClose Vein Sealing Systems in the European market for the treatment of varicose veins. Biolas introduces VariClose in Europe

Lombard Medical acquires EVAR stent graft developer Altura Medical
Friday, 31 Jul 2015
Altura Medical has developed an ultra-low profile endovascular stent graft technology that, according to Lombard, offers a simple and predictable solution for the treatment of standard abdominal ... Lombard Medical acquires EVAR stent graft developer Altura Medical

Sorry, I don’t speak IR
Wednesday, 12 Aug 2015
Two recently published papers in the Journal of Vascular and Interventional Radiology (JVIR) reveal that patient materials in interventional radiology available online are way above the understanding ... Sorry, I don’t speak IR

Features


Patient selection is key for SIRT with first-line chemotherapy
Tuesday, 18 Aug 2015
Ricky Sharma, professor and honorary consultant of Clinical Oncology at the University of Oxford and Oxford University Hospitals Trust tells Interventional News: “We need to know more about patient ... Patient selection is key for SIRT with first-line chemotherapy

Choosing horses for courses: Using liquid agents to embolize endoleaks
Monday, 27 Jul 2015
Robert Morgan, vascular interventional radiologist, St Georges Hospital, London, UK, tells Interventional News why he uses liquid embolic agents, such as ethylene vinyl oxide copolymer (EVOH-based) ... Choosing horses for courses: Using liquid agents to embolize endoleaks

Profiles


Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions